Galectin Therapeutics Inc.
DE ˙ DB ˙ US3632252025
1,88 € ↓ -0,05 (-2,59%)
2026-06-03
AKTIENPREIS
SecurityDE:PHPN / Galectin Therapeutics Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership106,401 shares
Latest Disclosed Value $ 442,628
Barclays Plc reports 272.20% increase in ownership of PHPN / Galectin Therapeutics Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 106,401 shares of Galectin Therapeutics Inc. (DE:PHPN) valued at $361,763 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 19, 2026 disclosing 28,587 shares of Galectin Therapeutics Inc.. This represents a change in shares of 272.20% during the quarter. The current value of the position is $200,034 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F GALECTIN THERAPEUTICS COM 363225202 106,401 77,814 272.20 443 466.67 0.0001
2026-03-19 2025-09-30 13F/A-2 GALECTIN THERAPEUTICS COM 363225202 28,587 28,587 79 0.0000
2026-02-27 2025-06-30 13F/A-2 GALECTIN THERAPEUTICS COM 363225202 0 -9,326 -100.00 0 -100.00
2025-08-14 2025-06-30 13F/A-1 GALECTIN THERAPEUTICS COM 363225202 0 -9,326 0 0.0000
2025-08-13 2025-06-30 13F GALECTIN THERAPEUTICS COM 363225202 0 0
2026-03-17 2025-03-31 13F/A-1 GALECTIN THERAPEUTICS COM 363225202 9,326 -45,308 -82.93 11 -84.29 0.0000
2025-05-15 2025-03-31 13F GALECTIN THERAPEUTICS COM 363225202 9,326 -45,308 0 0.0000
2026-03-19 2024-12-31 13F/A-1 GALECTIN THERAPEUTICS COM 363225202 54,634 26,047 91.11 70 -10.26 0.0000
2025-02-13 2024-12-31 13F GALECTIN THERAPEUTICS COM 363225202 54,634 26,047 0 0.0000
2026-03-31 2024-09-30 13F/A-2 GALECTIN THERAPEUTICS COM 363225202 28,587 21,598 309.03 79 420.00 0.0000
2024-11-19 2024-09-30 13F/A-1 GALECTIN THERAPEUTICS COM 363225202 28,587 21,598 0 0.0000
2024-11-15 2024-09-30 13F GALECTIN THERAPEUTICS COM 363225202 28,587 21,598 0 0.0000
2026-03-23 2024-06-30 13F/A-1 GALECTIN THERAPEUTICS COM 363225202 6,989 6,989 16 0.0000
2024-08-14 2024-06-30 13F GALECTIN THERAPEUTICS COM 363225202 6,989 6,989 0 0.0000
2022-02-23 2021-12-31 13F/A-1 GALECTIN THERAPEUTICS COM 363225202 0 -2,407 -100.00 0 -100.00
2022-02-14 2021-12-31 13F GALECTIN THERAPEUTICS COM 363225202 0 -2,407 0
2021-11-09 2021-09-30 13F GALECTIN THERAPEUTICS COM 363225202 2,407 -4,200 -63.57 9 -57.14 0.0000
2021-08-13 2021-06-30 13F GALECTIN THERAPEUTICS COM 363225202 6,607 -24,487 -78.75 21 -69.12 0.0000
2021-05-13 2021-03-31 13F GALECTIN THERAPEUTICS COM 363225202 31,094 19,088 158.99 68 151.85 0.0000
2021-02-11 2020-12-31 13F GALECTIN THERAPEUTICS COM 363225202 12,006 -5,274 -30.52 27 -41.30 0.0000
2020-11-12 2020-09-30 13F GALECTIN THERAPEUTICS COM 363225202 17,280 -3,771 -17.91 46 -28.12 0.0000
2020-08-12 2020-06-30 13F GALECTIN THERAPEUTICS COM 363225202 21,051 7,669 57.31 64 137.04 0.0000
2020-05-13 2020-03-31 13F GALECTIN THERAPEUTICS COM 363225202 13,382 -26,678 -66.60 27 -76.52 0.0000
2020-02-10 2019-12-31 13F GALECTIN THERAPEUTICS COM 363225202 40,060 20,188 101.59 115 59.72 0.0001
2019-11-15 2019-09-30 13F/A-1 GALECTIN THERAPEUTICS COM 363225202 19,872 -916 -4.41 72 -16.28 0.0000
2019-11-14 2019-09-30 13F GALECTIN THERAPEUTICS COM 363225202 19,872 -916 72 16.6465
2019-08-14 2019-06-30 13F GALECTIN THERAPEUTICS COM 363225202 20,788 -111,603 -84.30 86 -87.30 0.0001
2019-05-15 2019-03-31 13F GALECTIN THERAPEUTICS COM 363225202 132,391 -42,212 -24.18 677 13.02 0.0005
2019-02-14 2018-12-31 13F GALECTIN THERAPEUTICS COM 363225202 174,603 168,393 2,711.64 599 1,518.92 0.0005
2018-11-14 2018-09-30 13F GALECTIN THERAPEUTICS COM 363225202 6,210 3,016 94.43 37 85.00 0.0000
2018-08-14 2018-06-30 13F GALECTIN THERAPEUTICS COM 363225202 3,194 -16,929 -84.13 20 -79.17 0.0000
2018-05-15 2018-03-31 13F GALECTIN THERAPEUTICS COM 363225202 20,123 20,123 96 0.0001
2015-08-14 2015-06-30 13F GALECTIN THERAPEUTICS COM 363225202 0 -574 -100.00 0 -100.00
2015-05-19 2015-03-31 13F/A-1 GALECTIN THERAPEUTICS COM 363225202 574 -837 -59.32 1 -75.00 0.0000
2015-05-14 2015-03-31 13F GALECTIN THERAPEUTICS COM 363225202 574 1
2015-02-13 2014-12-31 13F GALECTIN THERAPEUTICS COM 363225202 1,411 1,224 654.55 4 300.00 0.0000
2014-11-14 2014-09-30 13F GALECTIN THERAPEUTICS COM 363225202 187 -208 -52.66 1 -80.00 0.0000
2014-08-14 2014-06-30 13F GALECTIN THERAPEUTICS COM 363225202 395 326 472.46 5 400.00 0.0000
2014-05-15 2014-03-31 13F GALECTIN THERAPEUTICS COM 363225202 69 -3,231 -97.91 1 -96.15 0.0000
2014-02-13 2013-12-31 13F GALECTIN THERAPEUTICS COM 363225202 3,300 2,800 560.00 26 420.00 0.0000
2013-11-14 2013-09-30 13F GALECTIN THERAPEUTICS COM 363225202 500 500 5 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.